Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 529 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Recruiting

Streamlining Radioembolization for Small HCC

NCT06979219

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • National Cancer Center Goyang, South Korea
  • Samsung Medical Center Seoul, South Korea
  • Seoul National University Hospital Seoul, South Korea
  • Severance hospital Seoul, South Korea
View Trial Details
Recruiting

Same-day Radioembolization for Large HCC

NCT06944483

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • National Cancer Center Goyang, South Korea
  • Samsung Medical Center Seoul, South Korea
  • Seoul National University Hospital Seoul, South Korea
  • Severance hospital Seoul, South Korea
View Trial Details
Recruiting

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

NCT06795022

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site St Louis, Missouri, United States
View all 20 locations
View Trial Details
Recruiting

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

NCT05733598

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Sylvester Comprehensive Cancer Center (University of Miami Hospital and Clinics) Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Recruiting

Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)

NCT07331883

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Sanming First Hospital Sanming, Fujian, China
  • The Third Bethune Hospital of Jilin University Changchun, Jilin, China
  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
  • Huashan Hospital, Fudan University Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions